AI assistant
CONMED Corp — Director's Dealing 2016
Mar 3, 2016
31971_dirs_2016-03-03_feac7f5b-581c-4154-b26d-9f673cbd5c96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-03-01
Reporting Person: Ruiz-Caban Wilfredo (EVP QA, RA and Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-01 | Rsus (restricted Stock Units) | $0 | A | 1500 | Acquired | 2026-03-01 | Common Stock (1500) | Direct |
| 2016-03-01 | Options To Purchase Common Stock | $39.87 | A | 29200 | Acquired | 2026-03-01 | Common Stock (29200) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period